|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - GBX | -.--% |
|
+0.65% | -29.32% |
| 14/12/17 | Vernalis : AGM Statement | PU |
| 14/12/17 | Vernalis PLC: AGM Statement | MW |
| 13/12/17 | Vernalis : enters into research collaboration with Daiichi Sankyo | PU |
| 13/12/17 | Vernalis : + Daiichi Sankyo Enter Collaboration | MW |
| 06/12/17 | Vernalis : and Servier Achieve Research Milestone in Third Oncology Collaboration | PU |
| Director | Title | Age | Since |
|---|---|---|---|
Todd Davis
BRD | Director/Board Member | 65 | 05/12/2022 |
Octavio Espinoza
BRD | Director/Board Member | 56 | 01/11/2022 |
Andrew Reardon
BRD | Director/Board Member | 52 | 01/11/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +0.65% | - | - | 0 | |
| -0.62% | -1.87% | +42.87% | +64.15% | 63.77B | |
| +0.35% | +3.20% | +14.40% | +81.76% | 56.37B | |
| +0.53% | +1.96% | +16.24% | +103.35% | 54.62B | |
| -2.81% | -4.31% | +23.50% | +47.83% | 44.06B | |
| -0.33% | -1.93% | +19.28% | +98.80% | 42.11B | |
| +0.55% | +2.31% | +225.14% | +866.21% | 41B | |
| +3.27% | +47.96% | +112.84% | +96.58% | 34.92B | |
| +1.22% | -1.44% | +14.57% | +46.95% | 32.82B | |
| +0.89% | +20.55% | -40.62% | +349.24% | 24.7B | |
| Average | +0.31% | +7.54% | +47.58% | +194.99% | 43.82B | |
| Weighted average by Cap. | +0.18% | +5.44% | +47.99% | +176.67% |
- Stock Market
- Stocks
- VER Stock
Select your edition
All financial news and data tailored to specific country editions
